Skip to main content
. 2023 Feb 6;38(7):612–629. doi: 10.1177/08850666231153393

Table A1.

The Included Parameters in the Data Sets with Their Descriptions, Additional Information, and Variable Type.

Parameter Description Comment Variable Type
Sex (female) Percentage of female patients N/A Categorical
BMI Body Mass Index N/A Numerical
Age (Q1, Q3) Median age with 25th and 75th percentiles N/A Numerical
SOFA Total SOFA score Ignores missing components Numerical
APACHE Total APACHE II score Ignores missing components Numerical
GCS score Total Glasgow Coma Scale-score N/A Numerical
ABP mean (mm Hg) Arterial blood pressure (mean) N/A Numerical
Heart rate (/min) Heart rate Either ECG, unspecified, or monitor Numerical
Hemoglobin (mmol/l) Hemoglobin Either arterial, blood, mixed venous, unspecified, venous, or bloodgas Numerical
AKI The creatinine component of the AKI (Acute Kidney Injury) score N/A Numerical
Urea/creatinine ratio Urea over creatinine N/A Numerical
PO2 arterial (mm Hg) Partial pressure O2 (arterial) N/A Numerical
Mean airway pressure (cmH2O) Mean airway pressure N/A Numerical
Peak pressure (cmH2O) Peak pressure N/A Numerical
PaO2/FiO2 PaO2/FiO2 ratio N/A Numerical
Tidal volume (ml/kg) Tidal volume per ideal body weight N/A Numerical
PCO2 arterial (mm Hg) Partial pressure CO2 (arterial) N/A Numerical
End tidal CO2 (mm Hg) End-tidal CO2 N/A Numerical
pH arterial pH arterial N/A Numerical
Respiratory system compliance (ml/cmH2O) Respiratory system compliance Either dynamic or unspecified Numerical
Driving pressure (cmH2O) Driving pressure N/A Numerical
Respiratory rate (/min) Respiratory rate Measured by ventilator Numerical
Ventilatory ratio Ventilatory ratio Calculated as: (minute ventilation (ml/min) · PaCO2 (mm Hg))/(predicted body weight · 100 · 37.5) Numerical
Mechanical power (joules/minute/kg PBW) Mechanical power per predicted body weight N/A Numerical
CRP (mg/l) C-reactive protein Either blood or unspecified Numerical
Temperature (°C) Temperature in degrees Celsius Either unspecified, rectal, esophageal, nasopharyngeal, groin, bladder, core, blood, axillary, or ear Numerical
Lymphocytes (%) Lymphocytes percentage N/A Numerical
APTT Activated partial thromboplastin time Either blood or unspecified Numerical
Prothrombin time (sec) Prothrombin time N/A Numerical
Anticoagulants Percentage of patients with anticoagulants intake Includes medications: heparin, dalteparin, enoxaparin, nadroparin, danaparoid, tinzaparin, clopidogrel, dipyridamole, carbasalate, epoprostenol, ticagrelor Categorical
Fluids Percentage of patients with fluids intake Includes medications: erythrocytes, thrombocytes, blood, solutions, carbohydrates, electrolytes Categorical
Vasopressors Percentage of patients with vasopressors intake Includes medications: isoprenaline, norepinephrine, dopamine, phenylephrine, dobutamine, epinephrine, ephedrine, milrinone, enoximone, vasopressin, desmopressin Categorical
Diuretics Percentage of patients with diuretics intake Includes medications: furosemide, bumetanide Categorical
Corticosteroids Percentage of patients with corticosteroids intake Includes medications: corticosteroids hydrocortisone, prednisolone, betamethasone, dexamethasone, betamethasone, dexamethasone, methylprednisolone, prednisolone, prednisone, hydrocortisone, cortisone, methylprednisolone Categorical
Other immunosuppressives Percentage of patients with other immunosuppressives intake Includes medications: anakinra, tocilizumab Categorical
Antibiotics Percentage of patients with antibiotics intake Includes medications: flucloxacillin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, meropenem, gentamicin, ciprofloxacin, vancomycin, metronidazole Categorical
Antimycotics Percentage of patients with antimycotics intake Includes medications: amphotericin, miconazole, ketoconazole, fluconazole, voriconazole, anidulafungin Categorical
Antivirals Percentage of patients with antivirals intake Includes medicationcyclovirvir, ganciclovir, valaciclovir, valganciclovir, ritonavir, oseltamivir, lopinavir, remdesivir Categorical
Musclerelaxants Percentage of patients with musclerelexants intake Includes medications: suxamethonium, rocuronium Categorical
Opioids Percentage of patients with opioids intake Includes medications: fentanyl, alfentanil, sufentanil, remifentanil, morphine, fentanyl, piritramide Categorical
Sedatives Percentage of patients with sedatives intake Includes medications: ketamine, etomidate, propofol, esketamine, diazepam, lorazepam, midazolam, dexmedetomidine Categorical